ArticleCell death & disease2018

ID1-induced p16/IL6 axis activation contributes to the resistant of hepatocellular carcinoma cells to sorafenib.

Lei-Lei Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.